Corridome

Kadmon Holdings, Inc

Sale November 9, 2021

From an SEC filing dated Nov 9, 2021

  1. Kadmon Holdings, Inc agreed to be sold to Sanofi, announced on Nov 9, 2021.

    8-K

  2. Cantor Fitzgerald & Co.firm and Moelis & Companyfirm advised the seller.

    8-K

  3. Centerview Partnersfirm advised the buyer.

    8-K

  4. H.c.wainwright & Co.firm advised on the deal.

    8-K

  5. The filing puts the value at $1.9B.

    8-K

  6. Cantor Fitzgerald & Co.firm also worked on Velaris Therapeutics, Incdeal, on Oct 13, 2026.

    8-K

Parties

first 2 of 5

PartyRoleSource
SanofiBuyer8-K
Cantor Fitzgerald & Co.Seller's adviser8-K

3 more parties

Sign up free to see all 5.

Sign up free

Value

KindAmountBasisSource
Disclosed$1.9Bequity value8-K

More deals

first 2 of 18

DateDealFirmsSource
Oct 26, 2026Surgery Partners, Inc · SaleBain Capital Private Equity, Centerview Partners8-K
Oct 21, 2026American Oncology Network, Inc · SaleMoelis & Company, Citigroup Global Markets8-K

16 more deals

Deals with Cantor Fitzgerald & Co., Moelis & Company and 2 more firms.

Sign up free to see the first 5, or become a member to see all 18.

Sign up freeBecome a member

On file

Date as stated
November 9, 20218-K
Filed by
Kadmon Holdings, Inc.8-K
Status
Completed8-K

Browse the register